Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...

Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...

It's also approved to treat binge-eating disorder in adults. Vyvanse is available as an orally administered (taken by mouth) ...

Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

Vyvanse capsules are supplied in bottles of 100 in the following strengths: 10 mg – pink body/pink cap (imprinted with S489 and 10 mg) 20 mg – ivory body/ivory cap (imprinted with S489 and 20 ...

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ...

Elite has launched Elite's a generic version of Vyvanse (lisdexamfetamine disylate) in dosage strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules. Generic Vyvanse is indicated ...

People who require medication for their attention deficit hyperactivity disorder (ADHD) continue to have a difficult time getting their prescriptions filled due to a lack of available medication.

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor ...